AMBER DANIELS: Open Payments
NPI 1952156887 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,447 in 136 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $2,033 · 2025 $2,447
Food & beverage: $2,447
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 40 | $542 |
| Lundbeck LLC | 26 | $329 |
| Neurocrine BioSciences, Inc. | 7 | $328 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $318 |
| Supernus Pharmaceuticals, Inc. | 15 | $195 |
| Corium, LLC | 6 | $151 |
| Axsome Therapeutics, Inc. | 3 | $140 |
| E.R. Squibb & Sons, L.L.C. | 7 | $132 |
| ABBVIE INC. | 5 | $81 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
Products named: ABILIFY MAINTENA, INGREZZA, CAPLYTA, REXULTI, Qelbree, ABILIFY ASIMTUFII, Azstarys, Auvelity.
Industry payments across TN — which companies pay providers there.
